Effect of recombinant human erythropoietin and doxorubicin in combination on the proliferation of MCF-7 and MDA-mb231 breast cancer cells
Patients with cancer often exhibit signs of anemia as the result of the disease. Thus, cancer chemotherapies often include erythropoietin (EPO) in the regime to improve the survival rate of these patients. The aim of the present study was to determine the effect of EPO on doxorubicin-treated breast...
Main Authors: | Radwan, Esam M., Abdullah, Rasedee, Al‑Qubaisi, Mothanna Sadiq, El Zowalaty, Mohamed E., Naadja, Seif‑Eddine, Mohamed Alitheen, Noorjahan Banu, Omar, Abdul Rahman |
---|---|
Format: | Article |
Language: | English |
Published: |
Spandidos Publications
2016
|
Subjects: | |
Online Access: | http://psasir.upm.edu.my/id/eprint/54047/1/Effect%20of%20recombinant%20human%20erythropoietin%20and%20doxorubicin.pdf |
Similar Items
-
Effects of tamoxifen-loaded erythropoietin-coated nanostructured lipid carrier on breast cancer cells and rat mammary gland tumour
by: Beh, Chaw Yee
Published: (2019) -
Treatment of MCF-7 and MDA-MB-231 human breast cancer cell lines with erythropoietin, doxorubicin and their combination
by: Radwan, Esam M.
Published: (2015) -
In vitro treatment of MCF-7 and MDA-MB-231 breast cancer cell lines with doxorubicin and vincristine sulphate calcium carbonate nanoparticles
by: Mengyi, Xue
Published: (2019) -
Effect of recombinant human erythropoietin and its combination with tamoxifen on viability of MCF-7 cell in three-dimensional culture
by: Shujaaedin, Hareth Yahya Ahmed
Published: (2019) -
Relationship between erythropoietin and hepcidin among transfused Malaysian adult thalassemic patients
by: Ibraheem, Shahad Mohammed
Published: (2022)